Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
- PMID: 1699472
- DOI: 10.1002/ana.410280213
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Abstract
The innervation of the cranial vessels by the trigeminal nerve, the trigeminovascular system, has recently been the subject of study in view of its possible role in the mediation of some aspects of migraine. Since stimulation of the trigeminal ganglion in humans leads to facial pain and flushing and associated release of powerful neuropeptide vasodilator substances, their local release into the extracerebral circulation of humans was determined in patients who had either common or classic migraine. Venous blood was sampled from both the external jugular and cubital fossa ipsilateral to the side of headache. Plasma levels of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide were determined using sensitive radioimmunoassays for each peptide, and values for the cubital fossa and external jugular and a control population were compared. A substantial elevation of the calcitonin gene-related peptide level in the external jugular but not the cubital fossa blood was seen in both classic and common migraine. The increase seen in classic migraine was greater than that seen with common migraine. The other peptides measured were unaltered. This finding may have importance in the pathophysiology of migraine.
Similar articles
-
Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.Cephalalgia. 1994 Feb;14(1):47-54. doi: 10.1046/j.1468-2982.1994.1401047.x. Cephalalgia. 1994. PMID: 7515329
-
Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.Keio J Med. 2011;60(3):82-9. doi: 10.2302/kjm.60.82. Keio J Med. 2011. PMID: 21979827 Review.
-
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.Ann Neurol. 1988 Feb;23(2):193-6. doi: 10.1002/ana.410230214. Ann Neurol. 1988. PMID: 2454066
-
Migraine and neuropeptides.Neuropeptides. 2015 Aug;52:19-30. doi: 10.1016/j.npep.2015.03.006. Epub 2015 Mar 30. Neuropeptides. 2015. PMID: 26094101 Review.
-
Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.Cephalalgia. 1990 Feb;10(1):39-50. doi: 10.1046/j.1468-2982.1990.1001039.x. Cephalalgia. 1990. PMID: 1690601
Cited by
-
The role of the immune system and the biomarker CD3 + CD4 + CD45RA-CD62L- in the pathophysiology of migraine.Sci Rep. 2020 Jul 23;10(1):12277. doi: 10.1038/s41598-020-69285-4. Sci Rep. 2020. PMID: 32704149 Free PMC article.
-
Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis.Pharmaceuticals (Basel). 2022 Sep 27;15(10):1189. doi: 10.3390/ph15101189. Pharmaceuticals (Basel). 2022. PMID: 36297301 Free PMC article. Review.
-
Association of dietary vitamin C consumption with severe headache or migraine among adults: a cross-sectional study of NHANES 1999-2004.Front Nutr. 2024 Jun 18;11:1412031. doi: 10.3389/fnut.2024.1412031. eCollection 2024. Front Nutr. 2024. PMID: 38962437 Free PMC article.
-
Antidromic vasodilatation and the migraine mechanism.J Headache Pain. 2012 Mar;13(2):103-11. doi: 10.1007/s10194-011-0408-3. Epub 2011 Dec 27. J Headache Pain. 2012. PMID: 22200764 Free PMC article. Review.
-
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.Neurol Ther. 2024 Apr;13(2):465-473. doi: 10.1007/s40120-024-00586-w. Epub 2024 Feb 15. Neurol Ther. 2024. PMID: 38361080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical